Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duobrii in Psoriasis Patients on Biologics
NCT04119102Phase 4Recruiting
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- Oct 2019
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of halobetasol propionate + tazarotene in plaque psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Started Oct 2019; status: recruiting.
02
Drugs
halobetasol propionate + tazarotene
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04119102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04119102.